Detalhe da pesquisa
1.
Transcriptome Analysis Reveals MFGE8-HAPLN3 Fusion as a Novel Biomarker in Triple-Negative Breast Cancer.
Front Oncol
; 11: 682021, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211850